- Investing Ideas
- /
- Australian High Growth Potential Companies
Australian High Growth Potential Companies
Results
358
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
358 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BOE | AU$2.95 | -7.5% | -35.6% | AU$1.2b | AU$4.23 | PE27.1x | E49.4% | n/a | Energy | ||
SKS | AU$2.07 | -1.9% | 536.9% | AU$238.7m | AU$2.15 | PE35x | E24.8% | 0.5% | Capital Goods | ||
BBT | AU$0.36 | 2.9% | 41.2% | AU$203.8m | AU$0.47 | PS3.5x | E87.6% | n/a | Consumer Services | ||
MX1 | AU$0.07 | -2.8% | -39.1% | AU$40.9m | AU$0.19 | PS2.7x | E68.7% | n/a | Healthcare | ||
CUV | AU$11.28 | -1.1% | -21.2% | AU$565.4m | AU$28.23 | PE15.8x | E26.2% | 0.4% | Pharmaceuticals & Biotech | ||
BTR | AU$0.021 | -4.5% | 61.5% | AU$239.5m | AU$0.05 | PS227.2x | E86.0% | n/a | Materials | ||
FND | AU$5.86 | 28.5% | 193.7% | AU$288.2m | AU$9.03 | PS4.3x | E133.7% | n/a | Diversified Financials | ||
PLT | AU$0.84 | 3.7% | 12.8% | AU$158.2m | AU$1.50 | PS1.8x | E120.1% | n/a | Diversified Financials | ||
ADR | AU$0.011 | -8.3% | -73.2% | AU$8.2m | AU$0.08 | PS9.8x | E73.7% | n/a | Healthcare | ||
NWF | AU$0.089 | 0% | -19.1% | AU$83.7m | AU$0.47 | PS40.6x | E72.1% | n/a | Materials | ||
PDN | AU$7.84 | -4.6% | -30.3% | AU$3.1b | AU$12.21 | PE37.3x | E51.0% | n/a | Energy | ||
GEN | AU$0.03 | -3.2% | n/a | AU$26.6m | AU$0.09 | PB0.5x | E117.7% | n/a | Materials | ||
MM8 | AU$0.16 | -3.0% | 171.2% | AU$63.5m | AU$0.32 | PS35.3x | E67.5% | n/a | Materials | ||
AVA | AU$0.10 | 0% | -47.5% | AU$30.5m | AU$0.30 | PS1x | E77.3% | n/a | Tech | ||
3DP | AU$0.074 | -6.3% | 64.4% | AU$54.1m | AU$0.31 | PS8.7x | E126.4% | n/a | Software | ||
ACR | AU$0.03 | -3.2% | -48.3% | AU$12.1m | AU$0.11 | PS2.4x | E91.8% | 0% | Pharmaceuticals & Biotech | ||
HGO | AU$0.045 | -4.3% | -32.8% | AU$92.2m | AU$0.087 | PS2.3x | E77.5% | 0% | Materials | ||
CYL | AU$4.01 | -6.7% | 762.4% | AU$940.1m | AU$4.25 | PE38.5x | E28.4% | n/a | Materials | ||
OPT | AU$1.01 | -0.5% | 62.9% | AU$1.2b | AU$1.20 | PS3040.9x | E60.4% | n/a | Pharmaceuticals & Biotech | ||
BOT | AU$0.52 | 5.1% | 178.4% | AU$921.9m | AU$0.65 | PS454.3x | E99.4% | n/a | Pharmaceuticals & Biotech | ||
EMR | AU$4.11 | -2.1% | 45.2% | AU$2.7b | AU$4.70 | PE32x | E34.7% | n/a | Materials | ||
CMM | AU$7.92 | -0.4% | 80.0% | AU$3.3b | AU$7.83 | PE37.5x | E25.6% | n/a | Materials | ||
GTI | AU$0.10 | 0% | -4.8% | AU$32.2m | AU$0.23 | PS1x | E103.7% | n/a | Software | ||
CCA | AU$0.07 | -2.8% | -2.8% | AU$48.1m | AU$0.14 | PS2.9x | E94.5% | n/a | Diversified Financials |